Insider · CIK 0001339895
Klara Dickinson
Files at CBAY (CymaBay Therapeutics, Inc.). First filing -, latest -.
In brief
Klara Dickinson files SEC Form 4 as officer at CBAY (CymaBay Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Klara Dickinson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Common Stock | -21,000 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -200,000 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -100,000 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -138,312 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -328,299 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -66,500 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -175,000 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -215,000 | - | - | 0 | Mar 22, 2024 |
| Mar 22, 2024 | CBAY CymaBay Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -78,000 | - | - | 0 | Mar 22, 2024 |
| Jan 24, 2024 | CBAY CymaBay Therapeutics, Inc. | AGrant or award Common Stock | +21,000 | $0.00 | $0 | 21,000 | Jan 26, 2024 |
| Jan 24, 2024 | CBAY CymaBay Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +78,000 | $0.00 | $0 | 78,000 | Jan 26, 2024 |
Questions about Klara Dickinson
Answered from the filings on this page, as of the latest one.
Is Klara Dickinson buying or selling?
Klara Dickinson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Klara Dickinson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Klara Dickinson has 0.
Where does Klara Dickinson file Form 4?
Klara Dickinson has filed Form 4 at CBAY (CymaBay Therapeutics, Inc.) as Chief Regulatory Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.